Axillary lymph node involvement at diagnosis can predict persistent nodal disease after neoadjuvant chemotherapy (neoCT) in brasilian patients (pts) with breast cancer (BC) (2002)
- Authors:
- USP affiliated authors: FOLGUEIRA, MARIA A. A. K. - FM ; CARVALHO, FILOMENA MARINO - FM ; BRENTANI, MARIA MITZI - FM ; FEDERICO, MIRIAM HATSUE HONDA - FM
- Unidade: FM
- Subjects: GÂNGLIOS LINFÁTICOS (PATOLOGIA); NEOPLASIAS MAMÁRIAS (QUIMIOTERAPIA); QUIMIOTERAPIA ADJUVANTE
- Language: Inglês
- Imprenta:
- Source:
- Título: Annals of Oncology,
- ISSN: 0923-7534
- Volume/Número/Paginação/Ano: v. 13, supl. 5, p. 42, res. 152, out., 2002
- Conference titles: ESMO Congress
-
ABNT
CASTRO, Gilberto et al. Axillary lymph node involvement at diagnosis can predict persistent nodal disease after neoadjuvant chemotherapy (neoCT) in brasilian patients (pts) with breast cancer (BC). Annals of Oncology,. Oxford: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 21 fev. 2026. , 2002 -
APA
Castro, G., Snitcovsky, I. M. L., Diz, M. P. E., Folgueira, M. A. A. K., Carelli, G., Bertoni, V. D., et al. (2002). Axillary lymph node involvement at diagnosis can predict persistent nodal disease after neoadjuvant chemotherapy (neoCT) in brasilian patients (pts) with breast cancer (BC). Annals of Oncology,. Oxford: Faculdade de Medicina, Universidade de São Paulo. -
NLM
Castro G, Snitcovsky IML, Diz MPE, Folgueira MAAK, Carelli G, Bertoni VD, Siqueira SAC, Carvalho FM, Brentani MM, Federico MHH. Axillary lymph node involvement at diagnosis can predict persistent nodal disease after neoadjuvant chemotherapy (neoCT) in brasilian patients (pts) with breast cancer (BC). Annals of Oncology,. 2002 ; 13 42.[citado 2026 fev. 21 ] -
Vancouver
Castro G, Snitcovsky IML, Diz MPE, Folgueira MAAK, Carelli G, Bertoni VD, Siqueira SAC, Carvalho FM, Brentani MM, Federico MHH. Axillary lymph node involvement at diagnosis can predict persistent nodal disease after neoadjuvant chemotherapy (neoCT) in brasilian patients (pts) with breast cancer (BC). Annals of Oncology,. 2002 ; 13 42.[citado 2026 fev. 21 ] - Casing a low c-erb-B2 expression after primary chemotherapy (PCT) predicts longer disease-free survival (DFS) in Brazilian patients with primary breast cancer
- Estudo da ploidia e indice proliferativo (fase s) por citometria de fluxo em carcinomas invasivos do colo uterino
- Transforming growth factor expression in head and neck cancer
- C-ERBB-2 negativo após quimioterapia neoadjuvante (QN) prediz sobrevida livre de doença (SLD) mais longa em pacientes com câncer de mama
- Lowcytometric S-phase fraction, but not ploidy nor hormmonal receptor status predicts survival in brazilian patients with operable breast cancer
- Doxorubicin, bleomycin, vincristine (ABV) or etoposide chemotherapy in AIDS: related poor risk Kaposi's sarcoma
- Disease free survical in breast cancer with high flowcytometric S phase fraction in Brazilian patients
- Tumor infiltrating lymphocytes express cd 1 b and beta4 integrin chain
- Thymocyte subpopulations and clonality in myasthenia gravis
- Flow-cytometric dna analysis and hormonal receptor status in brazilian breast cancer patients
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
